<?xml version="1.0" encoding="UTF-8"?>
<p>So far, many compounds with FTase inhibitory activity have been discovered and synthesised. What is more, many of them are now in the clinical trials. Oral FTIs developed in recent years have high bioavailability and selective antitumor activity 
 <italic>in vivo</italic>, and their potential effects may eventually be used to treat malignant tumours in humans. FTIs have also made significant achievements in the treatment of diseases such as premature aging and leukaemia
 <xref rid="CIT0133" ref-type="bibr">
  <sup>133–135</sup>
 </xref>.
</p>
